Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells

被引:68
作者
Kikuchi, T
Worgall, S
Singh, R
Moore, MAS
Crystal, RG [1 ]
机构
[1] Cornell Univ, Weill Med Coll, Dept Med, Div Pulm & Crit Care Med, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY USA
[3] Cornell Univ, Weill Med Coll, Belfer Gene Therapy Core Facil, New York, NY USA
[4] Cornell Univ, Weill Med Coll, Inst Med Genet, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, James Ewing Lab Dev Hematopoiesis, New York, NY 10021 USA
关键词
D O I
10.1038/80498
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have investigated whether dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can trigger B cells to produce antigen-specific antibodies without CD4(+) T-cell help. Dendritic cells modified with a recombinant adenovirus vector to express CD40 ligand and pulsed with heat-killed Pseudomonas induced naive B cells to produce antibodies against Pseudomonas in the absence of CD4(+) T cells in vitro, initiated Pseudomonas-specific humoral immune responses in vivo in wild-type and CD4(-/-) mice, and protected immunized wild-type and CD4(-/-), but not B-cell(-/-) mice, from lethal intrapulmonary challenge with Pseudomonas. Thus, genetic modification of dendritic cells with CD40 ligand enables them to present a complex mixture of microbial antigens and establish CD4(+) T cell-independent, B cell-mediated protective immunity against a specific microbe.
引用
收藏
页码:1154 / 1159
页数:6
相关论文
共 37 条
[11]   Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes [J].
Dubois, B ;
Vanbervliet, B ;
Fayette, J ;
Massacrier, C ;
VanKooten, C ;
Briere, F ;
Banchereau, J ;
Caux, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (05) :941-951
[12]   Enhancement of T cell-independent immune responses in vivo by CD40 antibodies [J].
Dullforce, P ;
Sutton, DC ;
Heath, AW .
NATURE MEDICINE, 1998, 4 (01) :88-91
[13]   Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA(1) and IgA(2) [J].
Fayette, J ;
Dubois, B ;
Vandenabeele, S ;
Bridon, JM ;
Vanbervliet, B ;
Durand, I ;
Banchereau, J ;
Caux, C ;
Briere, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (11) :1909-1918
[14]  
Ferlin WG, 1998, EUR J IMMUNOL, V28, P525, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt
[15]  
525::AID-IMMU525&gt
[16]  
3.0.CO
[17]  
2-M
[18]  
GOLD MR, 1994, ADV IMMUNOL, V55, P221
[19]   CD40 and CD154 in cell-mediated immunity [J].
Grewal, IS ;
Flavell, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :111-135
[20]  
Gurunathan S, 1998, J IMMUNOL, V161, P4563